Pasar al contenido principal

RecuperacIón y reutilización de Materias Primas auxiLIares de fabricaCIón

CPP2023-010867

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Transferencia de Conocimiento
Convocatoria Proyectos en Colaboración Público-Privada
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario SOLTECO MADERA PLASTICA S.L.U.

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Viral distribution of wild boar exposed to low (vaccine candidate) and high virulence African swine fever virus isolates: Immunohistochemical characterization

  • Porras, Néstor
  • Rodríguez-Bertos, Antonio
  • Barroso-Arévalo, Sandra
  • Kosowska, Aleksandra
  • Díaz-Frutos, Marta
  • De Pablo-Moreno, Javier M.
  • Sánchez-Segovia, Mónica
  • Barasona, José A.
Although several biosecurity and control measures are currently in place to mitigate the African swine fever (ASF) epidemic, vaccination is being explored as a potential long-term strategy. However, standardized guidelines for evaluating the safety and efficacy of ASF vaccines are not yet fully established. Understanding infection dynamics in wild boar is crucial, as they play a key role in the spread and persistence of the virus. This work aims to provide comprehensive information on viral distribution through immunohistochemical analysis (p72) with histopathologic assessment in wild boar. The study design comprises animals: (i) intramuscular infected with the high-virulence genotype II isolate Arm07 (highly virulent isolate [HVI]; n = 6); (ii) orally vaccinated with the low virulence isolate Lv17/WB/Rie1-ΔCD (low virulent isolate [LVI]; n = 6); and (iii) orally vaccinated with Lv17/WB/Rie1-ΔCD, either with a single dose (LVI-HVI1; n = 6) or repeated doses (LVI-HVI2; n = 6), followed by intramuscular challenge with Arm07. Clinical monitoring, viral load quantification in blood and tissues via real-time quantitative PCR, and virus viability in tissue cultures using peripheral blood mononuclear cells were performed. HVI animals had hemorrhagic and inflammatory lesions, along with generalized lymphoid depletion, correlated with widespread viral dissemination. LVI animals rarely showed mild lymphoid depletion of the lymph nodes; minimal immunostaining was observed in macrophages of the tonsils and lymph nodes, typically restricted to the oral entry point. A few LVI–HVI1 cases had infected resident sinus macrophages related to necrotic lesions at tonsils and lymph nodes, preventing the virus from disseminating to vital organs. No viral immunostaining or associated histopathologic lesions were observed in LVI–HVI2 animals, indicating that revaccination enhances safety against virulent challenges. Observed changes following vaccination do not reflect chronic infection but rather a transient one, followed by lymphoid system recovery. Immunohistochemical and histological evaluation has proven valuable in advancing our understanding of ASF pathogenesis in wild boar, contributing to improved vaccination safety and disease management strategies., This research was funded by the Research Project (Grant CPP2023-010867), financed by MICIU/AEI/10.13039/501100011033 and by FEDER, EU. Jose Ángel Barasona is a recipient of a “Ramón y Cajal” contract (Grant RYC2022-038060-I) funded by the Spanish Ministry of Science and Innovation (MCIN/AEI) and Fondo Social Europeo Plus (FSE+)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ineffective oral immunization of wild boar with the attenuated African swine fever virus NH/P68 grown in MA104 cell line

  • Kosowska, Aleksandra
  • Sánchez-Segovia, Mónica
  • Fernández-Pinero, Jovita
  • Porras, Néstor
  • Barroso-Arévalo, Sandra
  • Sánchez-Morales, Lidia
  • Díaz-Frutos, Marta
  • Barasona, José A.
African swine fever (ASF) is a highly contagious and lethal hemorrhagic disease affecting domestic pigs and wild boar, with serious consequences for animal health, the swine industry, and socio-economic stability. Given the lack of effective treatments and the limited success of conventional control measures, live attenuated vaccines (LAVs) have emerged as the most promising option, particularly for oral administration in free-ranging wild boar. The naturally attenuated genotype I isolate NH/P68 has shown protective potential in domestic pigs but retains residual virulence and persistence risks. To increase attenuation and facilitate large-scale production, the isolate was adapted to the MA104 continuous cell line. In this study, we assessed the safety and efficacy of NH/P68-MA104 in wild boar using an oral prime-boost immunization protocol (a primary dose of 10⁴ TCID₅₀/mL followed by two booster doses of 10⁵ TCID₅₀/mL), followed by a challenge with 10 HAD₅₀/mL of the virulent genotype II Armenia07 (Arm07) isolate. Oral administration of NH/P68-MA104 was safe, with no adverse effects observed throughout the vaccination period. Only one animal developed transient viremia, which was accompanied by clinical signs and a detectable antibody response. Two additional animals showed mild viremia, while the remaining animals displayed no evidence of infection or seroconversion before the challenge. After the challenge, vaccinated wild boar were not protected: all animals developed fever, viremia, and clinical signs consistent with acute ASF and succumbed at 14 ± 3 days post-challenge (dpc), comparable to in-contact and intramuscularly (IM) infected controls. These results demonstrate that oral immunization of wild boar with NH/P68-MA104 is safe but ineffective under the tested conditions. Continued research is needed to refine vaccine candidates and delivery strategies to achieve effective immunization of wild boar., This research was funded by the Research Project CPP2023–010867, financed by MICIU/AEI/10.13039/501100011033 and by FEDER, EU. José A. Barasona is a recipient of a ‘Ramón y Cajal’ contract (RYC2022–038060-I) funded by the Spanish Ministry of Science and Innovation (MCIN/AEI) and Fondo Social Europeo Plus (FSE+). Lidia Sánchez-Morales is a recipient of a University Complutense of Madrid and Banco Santander-funded PhD fellowship with reference CT15/23., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Editorial: Pathogen transmission at the domestic-wildlife interface: a growing challenge that requires integrated solutions, volume II

  • Jiménez-Ruiz, Saúl
  • Jori, Ferran
  • Santos, Nuno
  • Barasona, José A.
  • Fine, Amanda E.
SJ-R received support by the postdoctoral contracts Juan de la Cierva (JDC2022-048850-I) and Junior UCLM (2024/68292) funded by the MCIN/AEI/10.13039/501100011033, the EU NextGenerationEU/PRTR, and the FSE+. JAB is a recipient of a Ramón y Cajal contract [RYC2022-038060-I] funded by the Spanish Ministry of Science and Innovation (MCIN/AEI) and Fondo Social Europeo Plus (FSE+). This research was partially funded by Research Project CPP2023–010867, financed by MICIU/AEI/10.13039/501100011033 and by the European Union through FEDER., Peer reviewed